Old Web
English
Sign In
Acemap
>
Paper
>
Overcoming Barriers to Biosimilar Adoption: Commentary on "Cost to Medicare of Delayed Adalimumab Biosimilar Availability".
Overcoming Barriers to Biosimilar Adoption: Commentary on "Cost to Medicare of Delayed Adalimumab Biosimilar Availability".
2021
Nitzan Arad
adam Kroetsch
Mark McClellan
Keywords:
Biosimilar
Intensive care medicine
Adalimumab
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
0
Citations
NaN
KQI
[]